RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Amphastar Pharmaceuticals Stock

Amphastar Pharmaceuticals ROCE 2024

Amphastar Pharmaceuticals ROCE

0.31

Ticker

AMPH

ISIN

US03209R1032

WKN

A11664

In 2024, Amphastar Pharmaceuticals's return on capital employed (ROCE) was 0.31, a 53.59% increase from the 0.2 ROCE in the previous year.

Amphastar Pharmaceuticals Aktienanalyse

What does Amphastar Pharmaceuticals do?

Amphastar Pharmaceuticals Inc is a leading biopharmaceutical company that focuses on the development, manufacturing, and marketing of generic and innovative drugs. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. History Amphastar Pharmaceuticals has a remarkable history in the generic industry. The company was founded by Dr. Jack Y. Zhang and Dr. Zhaocheng Guo, both of whom had doctorates in pharmacy. They initially worked as scientists at other pharmaceutical companies before deciding to start their own company. The beginning was difficult as they had limited financial resources and faced tough competition in the industry. However, the company grew through acquiring smaller competitors and developing its own products. Business Model Amphastar Pharmaceuticals' business model is based on the development, manufacturing, and marketing of generic drugs that meet medical needs. The company specializes in the treatment of diseases such as diabetes, heart disease, infections, and cancer. Utilizing unused patents and collaborations plays an important role in accessing new markets. Divisions Amphastar Pharmaceuticals is divided into three divisions: Human Pharmaceuticals, Veterinary Pharmaceuticals, and API (Active Pharmaceutical Ingredients). The Human Pharmaceuticals division specializes in developing products for the treatment of diseases such as diabetes, heart disease, infections, and cancer. The Veterinary Pharmaceuticals division focuses on developing veterinary drugs for livestock and pets. The API division is responsible for manufacturing raw materials for the pharmaceutical industry. Products Amphastar Pharmaceuticals offers a wide range of products, including inhalation aids for asthma, antidepressants, antidotes for anesthetics, anesthetics, drugs for cancer therapies, as well as for the treatment of HIV infections and nervous system disorders. In the field of veterinary products, Amphastar produces antibiotics, antifungals, vitamins, and hormones for animals. Conclusion Amphastar Pharmaceuticals Inc is a successful biopharmaceutical company specializing in the development, manufacturing, and marketing of generic and innovative drugs for a wide range of diseases. Since its inception, the company has been focused on growth and has continuously evolved through acquiring smaller competitors and developing its own products. The company offers a wide range of products for use in human and veterinary medicine and places special emphasis on providing high-quality drugs. Amphastar Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Amphastar Pharmaceuticals's Return on Capital Employed (ROCE)

Amphastar Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Amphastar Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Amphastar Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Amphastar Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Amphastar Pharmaceuticals stock

What is the ROCE (Return on Capital Employed) of Amphastar Pharmaceuticals this year?

The ROCE of Amphastar Pharmaceuticals is 0.31 undefined this year.

How has the ROCE (Return on Capital Employed) of Amphastar Pharmaceuticals developed compared to the previous year?

The ROCE of Amphastar Pharmaceuticals has increased by 53.59% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Amphastar Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that Amphastar Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Amphastar Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that Amphastar Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Amphastar Pharmaceuticals impact the company?

An increase in the ROCE of Amphastar Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Amphastar Pharmaceuticals affect the company?

A decrease in ROCE of Amphastar Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Amphastar Pharmaceuticals?

Some factors that can affect Amphastar Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Amphastar Pharmaceuticals so important for investors?

The ROCE of Amphastar Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Amphastar Pharmaceuticals take to improve the ROCE?

To improve the ROCE, Amphastar Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Amphastar Pharmaceuticals pay?

Over the past 12 months, Amphastar Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amphastar Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Amphastar Pharmaceuticals?

The current dividend yield of Amphastar Pharmaceuticals is .

When does Amphastar Pharmaceuticals pay dividends?

Amphastar Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Amphastar Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amphastar Pharmaceuticals located?

Amphastar Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amphastar Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amphastar Pharmaceuticals from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Amphastar Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Amphastar Pharmaceuticals in the year 2023?

In the year 2023, Amphastar Pharmaceuticals distributed 0 USD as dividends.

In which currency does Amphastar Pharmaceuticals pay out the dividend?

The dividends of Amphastar Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Amphastar Pharmaceuticals

Our stock analysis for Amphastar Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amphastar Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.